Benjamin Xu, M.D., Ph.D. received his B.S. from Yale University and M.D. and Ph.D. in neuroscience from Columbia University. He then completed his ophthalmology residency at the LAC+USC Medical Center / USC Roski Eye Institute and glaucoma fellowship at the UCSD Shiley Eye Institute with Dr. Robert Weinreb. He is now acting chief of the glaucoma service at the USC Roski Eye Institute. His NIH-funded research focuses on developing new clinical tools to detect and care for patients with angle closure using artificial intelligence (AI) and anterior segment OCT (AS-OCT). He also studies the impact of primary angle closure glaucoma (PACG) on patient populations and healthcare systems in the United States using epidemiological and electronic healthcare data.